Kooman & Associates’s Johnson & Johnson JNJ Stock Holding History

Kooman & Associates’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$253K	Sell	998 -32	-3%	-$7.46K	0.07%	49
2026 Q1	$252K	Sell	1,030 -420	-29%	-$97.8K	0.08%	43
2025 Q4	$300K	Sell	1,450 -333	-19%	-$65.9K	0.09%	43
2025 Q3	$331K	Sell	1,783 -97	-5%	-$16.6K	0.1%	42
2025 Q2	$287K	Sell	1,880 -31	-2%	-$4.76K	0.1%	42
2025 Q1	$317K	Buy	+1,911	New	+$299K	0.12%	35
2024 Q4	–	Sell	-1,549	Closed	-$251K	–	50
2024 Q3	$251K	Buy	+1,549	New	+$247K	0.09%	41
2023 Q3	–	Sell	-1,338	Closed	-$221K	–	41
2023 Q2	$221K	Buy	1,338 +38	+3%	+$6.13K	0.11%	38
2023 Q1	$202K	Sell	1,300 -35	-3%	-$5.65K	0.11%	41
2022 Q4	$236K	Buy	+1,335	New	+$231K	0.23%	34

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Kooman & Associates's JNJ Position: Q2 2026 in Review

Kooman & Associates reduced its Johnson & Johnson (JNJ) stake by 3.1% in Q2 2026, selling an estimated $7.46K and leaving 998 shares worth $253K. The position accounts for 0.07% of the portfolio, ranked #49.

Kooman & Associates first reported a position in JNJ in Q4 2022 and has held it in 10 quarters since. The position peaked at $331K in Q3 2025. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Kooman & Associates held 998 shares of Johnson & Johnson worth $253K as of Q2 2026.
Kooman & Associates sold 32 Johnson & Johnson shares in Q2 2026, an estimated $7.46K.
Johnson & Johnson made up 0.07% of Kooman & Associates's portfolio in Q2 2026, its #49 holding.
Kooman & Associates first reported a position in Johnson & Johnson in Q4 2022 and has held it in 10 quarters since.
Kooman & Associates's Johnson & Johnson position peaked at $331K in Q3 2025.
4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Kooman & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.